drugset / Trial / NCT02681705

Radiation Therapy and Combination Chemotherapy for Medulloblastoma

NCT02681705 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying giving radiation therapy together with combination chemotherapy after surgery to see how well it works in treating children with newly diagnosed medulloblastoma.

Timeline

Start
2010-01
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 200 mg/m2 —

Indications